Class of 2016: Progress from the first St. Baldrick’s Robert J. Arceci Innovation Awardees
The volunteers who make up the St. Baldrick’s Foundation certainly “think different” when raising money for childhood cancer research. And thinking outside the box was a trademark of the late great Dr. Bob Arceci – a St. Baldrick’s shavee, board member and world-renowned researcher.
In his memory, the St. Baldrick’s Robert J. Arceci Innovation Awards were created. The goal was to give doctors the freedom and flexibility to think outside the box – to explore avenues that may have been left unexplored otherwise. The grants are unrestricted, making them unique in cancer research. And they are big awards, at $250,000 a year for 3 years.
The first class of researchers to receive these innovation awards began in 2016. Dr. Charles Mullighan, from St. Jude Children’s Research Hospital received the North America award, and Dr. Sam Behjati, from Wellcome Sanger Institute in the U.K., received the International award. Read on to find out where they are now:
2020 Infrastructure Grants: Critical to Giving Kids the Best Treatment Options
Enrollment on a clinical trial is often a child’s best hope for a cure.
Clinical trials offer children in treatment hope for a better future with fewer side effects. Clinical trials also help scientists to improve upon the standard treatments of today, making significant strides towards more effective and less toxic cures for children now and in the future.
Research Outcomes: Progress to Give Kids a Lifetime
In a year when it feels like most things have stopped due to the pandemic, research continues. While most research labs were affected by shutdowns for a time, researchers have found ways to carry on, working hard to find cures for childhood cancers and give survivors long and healthy lives. Read on to see a few interesting outcomes you’ve made possible.
OUT-OF-THE-BOX THINKER RECEIVES AWARD FOR INNOVATION
Unthinkable.
That’s how Dr. Olivier Ayrault described the loss of two school friends to cancer when he was growing up. The experience left an indelible imprint on him and he believes set his course in life to do something to fight cancer.
What You Should Know About Research into Rare Pediatric Cancers
Rare Cancer Day is September 30th, but the St. Baldrick’s Foundation fights rare cancers year-round.
What is rare disease?
When it comes to cancer, or even diseases as a whole, “rare” is a misleading word.
A rare disease is defined as “any disease or condition that affects fewer than 200,000 people in the United States, or about 1 in 1,500 people.” About 72% of rare diseases are genetic, and of those, 70% start in childhood.
Worldwide, people with rare diseases make up less than 6% of the population. But more than 6,000 rare diseases have been identified so far, and they affect more than 300 million around the world. If these people were a country, they would be the world’s third largest nation.
The Impact of the Dream Team on Childhood Cancers: A Video
The St. Baldrick’s — Stand Up To Cancer Pediatric Dream Team’s innovative and collaborative approach to science is making huge impacts in the world of childhood cancer research.
Patient Advocates – A Dream Team Video
Patient advocates play a vital role in the St. Baldrick’s — Stand Up To Cancer Pediatric Dream Team.
Patient advocates help to put a face on childhood cancer research. They humanize why the research is so critically important and translate that incredible work into language that’s more easily understood. Many are parents of kids who have fought cancer and one is a survivor herself. All are working to see the day when no family has to endure what they have.
Join us today and #DFYchildhoodCancers!
Read more on the St. Baldrick’s blog:
Proud To Be – A Dream Team Video
Researchers and patient advocates are proud to be part of the St. Baldrick’s – Stand Up To Cancer Pediatric Dream Team. Proud to be part of a collaboration to conquer childhood cancers.
The work the Dream Team is doing offers hope to children with cancer and their families and we’re closer than ever to finding cures. Not only has the Dream Team propelled ground-breaking cell therapies for blood cancers, it’s also making great progress towards the tougher challenge – helping kids with solid tumors. St. Baldrick’s supporters can be proud of this work that is already saving lives.
Join us today and #DFYchildhoodCancers!
Read more on the St. Baldrick’s blog:
What is the Dream Team? – A Dream Team Video
The St. Baldrick’s – Stand Up To Cancer Pediatric Dream Team is doing science differently to cure the incurable.
ANNOUNCING ST. BALDRICK’S JULY 2020 GRANTS
This is it! You — St. Baldrick’s donors and participants — have poured your passion into funding childhood cancer research, even in difficult times like these. And because of you, today we all celebrate the biggest batch of new grants of the year.
This new investment of $12.9 million brings the total granted by St. Baldrick’s for research since 2005 to more than $300 million.
The 53 grants include new funding for 18 Research Grants, 5 Supportive Care Research Grants, 9 St. Baldrick’s Scholars, and 1 International Scholar from India. Also receiving new funding for projects already underway are 7 St. Baldrick’s Scholars, 2 International Scholar from Kenya, 8 team science projects (Consortium grants), 1 St. Baldrick’s Innovation Award and 1 Strategic Initiative.
Older Posts »
SBF
Tweets »
